Numcure Pharmaceutical Private Limited
About Numcure Pharmaceutical Private Limited
Data last updated:
Numcure Pharmaceutical Private Limited is a private limited company based in Ongole, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 September 2022.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24290AP2022PTC122928. Its GSTIN is 08AAICN5251F1ZG (Rajasthan).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ramesh Kumar Bishnoi and Palu Devi Bishnoi.
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 19 – 2 – 5/4 T B Road Revenue Ward No. 11 Ongole, Andhra Pradesh, India – 523001.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.49 Lakh, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹89,790 (net margin 5.8%) and EBITDA of ₹71,262 (EBITDA margin 4.6%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address19 – 2 – 5/4 T B Road Revenue Ward No. 11 Ongole, Andhra Pradesh, India – 523001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Numcure Pharmaceutical Private Limited
The main business activity of Numcure Pharmaceutical is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Numcure Pharmaceutical Private Limited FY 2025 filings available
Numcure Pharmaceutical Private Limited reported revenue of ₹15.49 Lakh (up 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Numcure Pharmaceutical Private Limited
Revenue rose 18% in the latest year. EBITDA rose 45% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Numcure Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹71,262 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹89,790 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Numcure Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 4.6% | •••• | •••• |
| Net Profit Margin | 5.8% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Numcure Pharmaceutical are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Numcure Pharmaceutical Private Limited
Numcure Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eco-Dynamic Sun Chemcon Private Limited | ₹15.72 Lakh (FY 2024) | •••• | •••• | -4.0% | •••• | Nashik, Maharashtra, India |
| Vindhyan Ayurvedic Pharmaceuticals Pvt Ltd | ₹15.64 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Ernakulam, Kerala, India |
| Revolutionlife Pharmaceuticals Private Limited | ₹15.53 Lakh (FY 2020) | •••• | •••• | 41.0% | •••• | Lucknow, Uttar Pradesh, India |
| Maitree Research Private Limited | ₹15.5 Lakh (FY 2025) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Baljiwan Herbal Care Private Limited | ₹15.5 Lakh (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Numcure Pharmaceutical Private Limited this company | ₹15.49 Lakh (FY 2025) | •••• | •••• | 18.0% | •••• | Ongole, Andhra Pradesh, India |
| The Ethical Pharmaceutical Co. Private Limited | ₹15.46 Lakh (FY 2025) | •••• | •••• | -30.0% | •••• | Mumbai, Maharashtra, India |
| Drhealth Pharmaceuticals Private Limited | ₹15.44 Lakh (FY 2021) | •••• | •••• | -58.0% | •••• | Palghar West, Maharashtra, India |
| Snoval Pharmaceuticals Pvt Ltd | ₹15.4 Lakh (FY 2024) | •••• | •••• | 3.0% | •••• | Mumbai, Maharashtra, India |
| Citadel Fine Pharmaceuticals Private Limited | ₹15.31 Lakh (FY 2024) | •••• | •••• | -1.0% | •••• | Chennai, Tamil Nadu, India |
| Boem Pharma B.P. Private Limited | ₹15.31 Lakh (FY 2025) | •••• | •••• | 471.0% | •••• | Haridwar, Uttarakhand, India |
Peers are the five companies nearest above and the five nearest below Numcure Pharmaceutical by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Numcure Pharmaceutical Private Limited
Numcure Pharmaceutical Private Limited is audited by PURAN LUTHRA & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PURAN LUTHRA & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Numcure Pharmaceutical Private Limited
Numcure Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramesh Kumar Bishnoi | Director | 30 Sep 2022 | 4 Years 0 Months | Current |
| Palu Devi Bishnoi | Director | 30 Sep 2022 | 4 Years 0 Months | Current |
Ownership and Shareholding of Numcure Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Numcure Pharmaceutical Private Limited
Numcure Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Numcure Pharmaceutical Private Limited
Numcure Pharmaceutical Private Limited has a workforce of 0 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Numcure Pharmaceutical Private Limited
Numcure Pharmaceutical Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Palu Devi Bishnoi was appointed as Director on 30 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Numcure Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Numcure Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Numcure Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Numcure Pharmaceutical Private Limited
Numcure Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAICN5251F1ZG | Rajasthan | Active | 05 Dec 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Numcure Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Numcure Pharmaceutical Private Limited
Numcure Pharmaceutical is an active private limited company based in Ongole, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 September 2022 (4+ years old) and is registered under CIN U24290AP2022PTC122928.
Numcure Pharmaceutical reported revenue of ₹15.49 Lakh for FY 2025 (up 18% YoY).
Numcure Pharmaceutical has 2 current directors:
- Ramesh Kumar Bishnoi - Director
- Palu Devi Bishnoi - Director
Numcure Pharmaceutical reported a net profit of ₹89,790 (net margin 5.8%) and EBITDA of ₹71,262 (EBITDA margin 4.6%) for FY 2025, as per its filed financial statements.
The GSTIN of Numcure Pharmaceutical is 08AAICN5251F1ZG, registered in Rajasthan.
The CIN (Corporate Identification Number) of Numcure Pharmaceutical is U24290AP2022PTC122928. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Numcure Pharmaceutical was incorporated on 30 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Numcure Pharmaceutical by revenue are Eco-Dynamic Sun Chemcon Private Limited, Vindhyan Ayurvedic Pharmaceuticals Pvt Ltd, Revolutionlife Pharmaceuticals Private Limited, Maitree Research Private Limited, Baljiwan Herbal Care Private Limited and 5 more, all in the Pharma industry (Formulations).
Palu Devi Bishnoi was appointed as Director on 30 Sep 2022. Ramesh Kumar Bishnoi was appointed as Director on 30 Sep 2022.
The registered office of Numcure Pharmaceutical is at 19 – 2 – 54 T B Road Revenue Ward No. 11 Ongole, Andhra Pradesh, India – 523001.
Numcure Pharmaceutical has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.